Jeffrey Wiezorek insider trades: Kite Pharma (KITE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 25, 2017 | KITE | ↓ Sell | 5,283 | $179.66 | $949K | Direct | Sep 27, 2017 (2d) |
| Jul 3, 2017 | KITE | ↓ Sell | 10,000 | $104.32 | $1.0M | Direct | Jul 6, 2017 (3d) |
| Mar 1, 2017 | KITE | ↓ Sell | 18,000 | $75.01 | $1.4M | Direct | Mar 2, 2017 (1d) |
| Feb 1, 2017 | KITE | ↓ Sell | 1,500 | $51.21 | $77K | Direct | Feb 6, 2017 (5d) |
| Jan 6, 2017 | KITE | ↓ Sell | 1,500 | $50.00 | $75K | Direct | Jan 10, 2017 (4d) |
| Dec 20, 2016 | KITE | ↓ Sell | 716 | $50.86 | $36K | Direct | Dec 22, 2016 (2d) |
| Dec 1, 2016 | KITE | ↓ Sell | 1,293 | $50.68 | $66K | Direct | Dec 5, 2016 (4d) |
| Dec 1, 2016 | KITE | ↓ Sell | 207 | $51.23 | $11K | Direct | Dec 5, 2016 (4d) |
| Nov 10, 2016 | KITE | ↓ Sell | 1,500 | $50.18 | $75K | Direct | Nov 14, 2016 (4d) |
| Oct 3, 2016 | KITE | ↓ Sell | 1,500 | $54.81 | $82K | Direct | Oct 5, 2016 (2d) |
| Sep 1, 2016 | KITE | ↓ Sell | 1,500 | $58.24 | $87K | Direct | Sep 2, 2016 (1d) |
| Aug 1, 2016 | KITE | ↓ Sell | 1,500 | $56.90 | $85K | Direct | Aug 2, 2016 (1d) |
| Jul 1, 2016 | KITE | ↓ Sell | 1,500 | $50.00 | $75K | Direct | Jul 5, 2016 (4d) |
| Jun 1, 2016 | KITE | ↓ Sell | 3,000 | $50.65 | $152K | Direct | Jun 2, 2016 (1d) |
| Mar 15, 2016 | KITE | ↓ Sell | 9,000 | $44.88 | $404K | Direct | Mar 17, 2016 (2d) |
| Feb 16, 2016 | KITE | ↓ Sell | 9,000 | $44.07 | $397K | Direct | Feb 18, 2016 (2d) |
| Jan 15, 2016 | KITE | ↓ Sell | 9,000 | $55.26 | $497K | Direct | Jan 19, 2016 (4d) |
| Dec 15, 2015 | KITE | ↓ Sell | 9,000 | $63.78 | $574K | Direct | Dec 17, 2015 (2d) |
| Nov 16, 2015 | KITE | ↓ Sell | 9,000 | $78.08 | $703K | Direct | Nov 18, 2015 (2d) |
| Oct 15, 2015 | KITE | ↓ Sell | 9,000 | $62.59 | $563K | Direct | Oct 19, 2015 (4d) |
| Sep 15, 2015 | KITE | ↓ Sell | 9,000 | $64.34 | $579K | Direct | Sep 17, 2015 (2d) |
| Aug 17, 2015 | KITE | ↓ Sell | 9,000 | $60.87 | $548K | Direct | Aug 19, 2015 (2d) |
| Jul 15, 2015 | KITE | ↓ Sell | 9,000 | $71.92 | $647K | Direct | Jul 20, 2015 (5d) |
| Jun 15, 2015 | KITE | ↓ Sell | 9,000 | $57.00 | $513K | Direct | Jun 17, 2015 (2d) |
| May 15, 2015 | KITE | ↓ Sell | 9,000 | $50.15 | $451K | Direct | May 19, 2015 (4d) |
| Jun 25, 2014 | KITE | ↑ Buy | 4,000 | $17.00 | $68K | Direct | Jun 17, 2015 (357d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jeffrey Wiezorek's insider trades
Jeffrey Wiezorek is SVP Clinical Development at Kite Pharma (KITE). Since Jun 25, 2014, Jeffrey has reported 1 open-market purchase worth $68K and 25 sales worth $10.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (22 filings), grants and awards (5 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KITE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.